BRCA2 and breast carcinoma: In the present study, we attempted to determine the prevalence of pathogenic or likely pathogenic variants of BRCA1 or BRCA2 among the selected group of patients with breast cancer (not diagnosed as mutation carriers with the standard screening procedure in 2003–2015).